Increasingly investigations showed that MALAT1 was not only a reliable metastasis-related biomarker but also a vital regulator involved in occurrence, invasiveness, drug resistance, and metastasis of various cancers such as HCC and lung cancer. This evidence concerns the gene MALAT1 and lung carcinoma.